Drug: VINCRISTINE SULFATE. Injury: Posterior reversible encephalopathy syndrome Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 124633073 | VINCRISTINE SULFATE. | Posterior reversible encephalopathy syndrome | MERCK | 2.00 YR | F | 17 KG | 20160715 | PL |
| 126068832 | VINCRISTINE SULFATE. | Posterior reversible encephalopathy syndrome | PFIZER | 34.00 YR | M | 0 | 20160830 | JP |
| 126422061 | VINCRISTINE SULFATE. | Posterior reversible encephalopathy syndrome | PFIZER | 65.00 YR | F | 0 | 20160810 | IT |
| 126732241 | VINCRISTINE SULFATE. | Posterior reversible encephalopathy syndrome | TEVA | 65.00 YR | F | 0 | 20160822 | IT |
| 127452841 | VINCRISTINE SULFATE. | Posterior reversible encephalopathy syndrome | FDA-CTU | 1.83 YR | M | 26 KG | 20160914 | US |
Total Records: 5 Number of Pages: 1